Class II · Moderate risk Ongoing
Walgreens
Reason Chemical Contamination: Presence of benzene
FDA Drug Recalls
2,277 recalls · Class II, newest first
Class II · Moderate risk Ongoing
Duloxetine Delayed-Release Capsules
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Class II · Moderate risk Ongoing
Duloxetine Delayed-Release Capsules
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Class II · Moderate risk Ongoing
Duloxetine Delayed-Release Capsules
Reason CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
Class II · Moderate risk Ongoing
Neupogen
Reason Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Class II · Moderate risk Ongoing
Neupogen
Reason Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
Class II · Moderate risk Ongoing
Metformin Hydrochloride Extended- Release 500mg
Reason Presence of Foreign Tablets/Capsules.
Class II · Moderate risk Ongoing
Prasugrel Tablets
Reason Failed Dissolution Specifications - low dissolution results
Class II · Moderate risk Ongoing
Zapzyt
Reason Chemical Contamination: Presence of benzene.
Class II · Moderate risk Ongoing
CURAD Alcohol Prep Pads
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Medline Alcohol Prep Pads
Reason Subpotent Drug
Class II · Moderate risk Ongoing
Morphine Sulfate 5 mg per 0.25 mL Oral Syringe
Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class II · Moderate risk Ongoing
Lorazepam 0.5 mg per 0.25 mL Oral Syringe
Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class II · Moderate risk Ongoing
Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral Syringe
Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class II · Moderate risk Ongoing
Simethicone 20 mg per 0.3 mL Oral Syringe
Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class II · Moderate risk Ongoing
Ergocalciferol - Vitamin D Supplement - 10 mcg
Reason Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class II · Moderate risk Ongoing
Iodo Blanco Iodides
Reason Defective Container: broken or leaking bottles.
Class II · Moderate risk Ongoing
Kids by babyganics SPF 50 mineral sunscreen totally tropical
Reason Chemical Contamination
Class II · Moderate risk Ongoing
Kids by babyganics SPF 50 totally tropical
Reason Chemical Contamination
Class II · Moderate risk Ongoing
Nelarabine Injection
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Ongoing
Nelarabine Injection
Reason Failed Impurities/Degradation Specifications
Class II · Moderate risk Ongoing
ViaMed Alcohol Prep Pads
Reason Lack of assurance of sterility and cGMP deviations observed at the manufacturing site.
Class II · Moderate risk Ongoing
Voriconazole Container Description: voriconazole The product…
Reason CGMP Deviations
Class II · Moderate risk Ongoing
Latanoprost NDC# 82187-1002-1 Container Description: Amber colour…
Reason CGMP Deviations
Class II · Moderate risk Ongoing
Chlorambucil Container Description: The product packed in double…
Reason CGMP Deviations